Literature DB >> 2810952

Cancer cell emboli in the pectoral lymphatics of patients with breast cancer.

K Nakao1, M Miyata, T Aono, N Ogino, T Tsumori, Y Kawashima.   

Abstract

In order to investigate the possibility of local recurrence in the pectoral muscles of patients who undergo modified radical mastectomies, the cancer cell involvement of the lymphatics associated with the pectoralis major muscle was studied in 39 patients who underwent a standard radical mastectomy for Stage I-III breast cancer. Cancer cell emboli were found in the transpectoral lymphatics of 2 patients (2/39 = 5.1 per cent) and in the pectoral fascial lymphatics of 6 patients (6/39 = 15.4 per cent). Two patients with fascial lymphatic cancer cell emboli were from a group of 14 patients with intramammary lymphatic tumor emboli of a low degree (ly 1). The other 6 patients with cancer cell emboli in either the pectoral fascia or the transpectoral lymphatics were from a group of 11 patients with intramammary lymphatic tumor emboli of a moderate degree (ly 2). There was a significant relationship between the intramammary and the pectoral lymphatic cancer cell emboli (Chi square test: (p less than 0.05). The results of this study therefore indicate that lymphatic cancer cell emboli in the pectoral fascia and muscle are an important risk factor for patients who undergo a modified radical mastectomy.

Entities:  

Mesh:

Year:  1989        PMID: 2810952     DOI: 10.1007/bf02471618

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  11 in total

1.  The lymphatics of the breast.

Authors:  R T TURNER-WARWICK
Journal:  Br J Surg       Date:  1959-05       Impact factor: 6.939

2.  Conservative radial mastectomy (Patey's operation).

Authors:  R S Handley; A C Thackray
Journal:  Ann Surg       Date:  1969-12       Impact factor: 12.969

3.  Lymphatic spread of mammary carcinoma. Role of non-interpectoral lymph nodes on dorsal surface of pectoralis major muscle and of interpectoral nodes.

Authors:  A Hultborn; L Hultén; B Roos; M Rosencrantz; B Rosengren; C Ahrén
Journal:  Acta Radiol Ther Phys Biol       Date:  1971-04

4.  Results of conservative treatment of breast cancer at ten and 15 years.

Authors:  G Crile
Journal:  Ann Surg       Date:  1975-01       Impact factor: 12.969

5.  Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer.

Authors:  D F Roses; D A Bell; T J Flotte; R Taylor; H Ratech; N Dubin
Journal:  Am J Clin Pathol       Date:  1982-12       Impact factor: 2.493

6.  A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients.

Authors:  W A Maddox; J T Carpenter; H L Laws; S J Soong; G Cloud; M M Urist; C M Balch
Journal:  Ann Surg       Date:  1983-08       Impact factor: 12.969

7.  A comparison of modified radical mastectomy to radical mastectomy in the treatment of operable breast cancer.

Authors:  R R Baker; A C Montague; J N Childs
Journal:  Ann Surg       Date:  1979-05       Impact factor: 12.969

8.  Breast-conserving treatment for breast cancer in Stockholm, Sweden, 1977 to 1981.

Authors:  B Cedermark; J Askergren; A Alveryd; U Glas; L Karnström; A Somell; N O Theve; A Wallgren
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

9.  Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma.

Authors:  F A Nime; P P Rosen; H T Thaler; R Ashikari; J A Urban
Journal:  Am J Surg Pathol       Date:  1977-03       Impact factor: 6.394

10.  Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli.

Authors:  P P Rosen; P E Saigo; D W Braun; E J Beattie; D W Kinne
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

View more
  1 in total

1.  Pectoral Fascia Preservation in Oncological Mastectomy to Reduce Complications and Improve Reconstructions: A Systematic Review.

Authors:  Jaco Suijker; Yara L Blok; Ralph de Vries; Monique P van den Tol; Nicole M A Krekel
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.